All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a Q3 report for PIERRE FABRE PHARMACEUTICALS INC. on October 17, 2025, reporting $10,000 in lobbying income.

Lobbying for PIERRE FABRE PHARMACEUTICALS INC. · Pharmaceutical manufacturer

All filings by BROWNSTEIN HYATT FARBER SCHRECK, LLP · Everything PIERRE FABRE PHARMACEUTICALS INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 17, 2025

Income

$10,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbying activity 1

Pharmacy

Issues related to drug development, rare disease innovations, and issues impacting the pharmaceutical industry.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.